Dolutegravir is a medicine used to manage HIV. Preventing the virus from inserting its own genetic material into white blood cells, the formula slows viral replication.
Dolutegravir belongs to a class of drugs called integrase inhibitors, which block a step the virus needs to insert its genetic material into your cells. This active compound is found in medicines such as Triumeq, Viropil and the single-ingredient product Dolutegravir.
Dolutegravir is commonly part of a combination regimen that controls HIV infection in adults and adolescents. Some people use it after starting treatment for the first time, while others switch to it to simplify their therapy. In Australia, it is one of the options recommended for long-term management of HIV.
Dolutegravir blocks the viral enzyme integrase, preventing the virus from inserting its DNA into human cells. Without that step, new virus particles cannot be made.
Pregnant people, those planning a pregnancy, or breastfeeding individuals should be aware that special considerations may apply. People with serious kidney or liver problems may need extra monitoring, and anyone with a known allergy to integrase inhibitors should avoid it.
Dolutegravir can interact with certain substances that affect how medicines are absorbed. Avoid taking high-dose antacids or supplements that contain calcium, iron, magnesium or zinc at the same time, and be cautious with alcohol or drugs that heavily affect liver enzymes. Always check the specific medication's labeling for exact interaction details.
If any of these serious signs appear, stop the medicine and get help right away.
Women who are pregnant or may become pregnant have shown higher sensitivity to certain risks. Older adults and people with existing liver or kidney disease also tend to notice side effects more often. Those taking other medicines that affect liver enzymes may experience stronger reactions.
Store Dolutegravir-containing medicines at room temperature, away from direct sunlight and moisture. Keep them out of reach of children and do not use them after the expiration date printed on the package. Some products are intended for long-term daily use, while others may be prescribed for a shorter course, depending on your treatment plan. For detailed usage, dosing, and administration, refer to the specific medication's clinical information.
This article is an educational overview of Dolutegravir, not medical advice. Medicines containing this ingredient (Triumeq, Viropil, Dolutegravir) may differ in formulation, strength, and directions. The information provided does not replace professional clinical judgment, and no liability is assumed for how it is used. Review the specific medication's labeling and seek guidance from a healthcare professional for personalized recommendations.
